OR WAIT null SECS
May 08, 2024
Progression in biopharmaceutical drug development and manufacturing is being boosted by technological advances.
May 04, 2024
A comparison between polysorbates and HPβCD determines the better stabilizer for biologics formulation.
April 17, 2024
ADC manufacturing facilities are requiring more stringent containment requirements as well as advanced analytical detection.
The Xcellerex magnetic mixer, single-use mixing system was designed to address challenges in large-scale mAb, vaccine, and genomic medicine manufacturing processes.
April 15, 2024
WMFTS’ new WMArchitect single-use solutions offers standard ready-to-use single-use assemblies as well as customized designs for biopharma fluid management.
April 02, 2024
Despite a growing trend toward single-use bioreactors, stainless-steel retains its relevance for certain products.
March 25, 2024
With the Vacaville, Calif., site acquisition, Lonza gains one of the largest biologics manufacturing sites for mammalian cell-based therapeutics.
March 15, 2024
The evolution of therapeutic modalities drives the adoption of single-use technologies.
ProBioGen and Mapp Biopharmaceutical will use the former’s GlymaxX technology to develop a cell line for an afucosylated antibody that targets Marburg virus infection
March 13, 2024
Under a new agreement, Chime Biologics will manufacture Domain Therapeutics’ antibody cancer immunotherapy candidate, DT-7012.